In this work, we propose a co-hitchhiking strategy for delivering PhA and recombinant IL-15 (rIL-15) via an engineered recombinant protein consisting of the IL-15Rα-sushi domain fused with the Fc domain of IgG to enhance cancer photoimmunotherapy (Scheme 1). Here, IL15 is linked to cancer.